IRIS UniCatt

Schinzari, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.342
AS - Asia 3.250
EU - Europa 2.938
SA - Sud America 548
Continente sconosciuto - Info sul continente non disponibili 154
AF - Africa 103
OC - Oceania 16
Totale 11.351
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.185
SG - Singapore 1.465
DE - Germania 617
CN - Cina 606
SE - Svezia 502
IT - Italia 471
BR - Brasile 446
VN - Vietnam 388
NL - Olanda 358
FR - Francia 252
IN - India 176
GB - Regno Unito 145
BD - Bangladesh 135
IE - Irlanda 120
FI - Finlandia 96
HK - Hong Kong 89
CA - Canada 85
JP - Giappone 80
PL - Polonia 80
ID - Indonesia 77
UA - Ucraina 76
RU - Federazione Russa 52
TR - Turchia 49
MX - Messico 43
CI - Costa d'Avorio 39
ES - Italia 38
AR - Argentina 36
IQ - Iraq 32
AT - Austria 24
BE - Belgio 24
KR - Corea 23
ZA - Sudafrica 21
IR - Iran 17
EC - Ecuador 16
AU - Australia 15
CZ - Repubblica Ceca 15
CO - Colombia 13
SA - Arabia Saudita 13
UZ - Uzbekistan 13
VE - Venezuela 13
RO - Romania 12
AE - Emirati Arabi Uniti 11
MA - Marocco 11
PK - Pakistan 11
JO - Giordania 10
CH - Svizzera 8
EG - Egitto 8
IL - Israele 8
PE - Perù 8
PH - Filippine 7
AL - Albania 6
AZ - Azerbaigian 6
CL - Cile 6
HR - Croazia 6
JM - Giamaica 6
LT - Lituania 5
NP - Nepal 5
SN - Senegal 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
DZ - Algeria 4
GR - Grecia 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
MY - Malesia 4
PA - Panama 4
PT - Portogallo 4
CY - Cipro 3
ET - Etiopia 3
EU - Europa 3
KE - Kenya 3
LU - Lussemburgo 3
NO - Norvegia 3
PY - Paraguay 3
UG - Uganda 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
IS - Islanda 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AW - Aruba 1
BB - Barbados 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
Totale 11.186
Salva come PNG Salva come JPEG
Città #
Singapore 895
Chandler 481
Ashburn 422
San Jose 386
Amsterdam 340
Los Angeles 194
New York 168
Ho Chi Minh City 136
Beijing 128
Dublin 119
Rome 112
Hanoi 101
Lauterbourg 84
Hong Kong 81
Frankfurt am Main 77
Tokyo 75
The Dalles 74
Jakarta 73
Warsaw 73
Dallas 71
Hyderabad 71
Wilmington 70
Hefei 66
San Mateo 65
Milan 61
St Louis 61
Ann Arbor 56
Fairfield 56
Helsinki 55
Chicago 53
Munich 52
São Paulo 52
Boston 47
Princeton 46
Nanjing 44
Jacksonville 43
Houston 40
Abidjan 39
Marseille 39
Santa Clara 39
Dearborn 35
North Bergen 35
Cattolica 33
Council Bluffs 33
London 33
Orem 33
Seattle 33
Moscow 31
Brooklyn 28
Falkenstein 26
Redwood City 26
Boardman 25
Nürnberg 25
Woodbridge 25
Brussels 24
Cambridge 24
Redmond 24
Nuremberg 23
Atlanta 22
Buffalo 22
Seoul 22
Toronto 22
Kent 21
Montreal 21
Bremen 20
Phoenix 20
Denver 19
Mexico City 19
Shanghai 19
Da Nang 18
Izmir 17
Nanchang 17
Chennai 16
Haiphong 16
Paris 16
Manchester 15
Rio de Janeiro 15
Stockholm 15
Augusta 14
Falls Church 14
Guangzhou 14
Lappeenranta 13
Turku 13
Hebei 12
Mumbai 12
San Francisco 12
Naples 11
Norwalk 11
Vienna 11
Washington 11
Amman 10
Changsha 10
Charlotte 10
Düsseldorf 10
Johannesburg 10
Lawrence 10
Leawood 10
Poplar 10
Tukwila 10
Ankara 9
Totale 6.280
Salva come PNG Salva come JPEG
Nome #
Contact skin radiotherapy (brachytherapy) for the treatment of non-melanoma skin cancers during COVID-19 pandemic 563
Pembrolizumab as first-line treatment for metastatic uveal melanoma 352
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 236
Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo 196
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 195
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 193
Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control study 193
The Role of Multidisciplinary Ocular and Periocular Cancers Meetings in Uveal Melanoma Management: A 2-Year Analysis 189
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 181
Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review 181
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 175
Multidisciplinary ocular and periocular cancers meetings: implementation in a tertiary referral center and analysis over a 12-months period 167
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 162
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 161
Are TKIs favourable for the elderly with non-small-cell lung cancer? 160
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 159
Gene expression profiling of pancreas neuroendocrine tumors with different ki67‐based grades 159
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study 157
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 156
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients 155
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 155
Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study 152
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 152
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 151
Hyperthermic intrathoracic chemotherapy combined to iterative cytoreductive surgery to treat a pleural carcinosis from psudomixoma peritonei. A case report 144
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 143
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 142
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 140
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 139
Methylation study of the Paris system for reporting urinary (TPS) categories 139
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 137
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 136
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 134
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 134
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 133
Skin cancer triage and management during COVID-19 pandemic. 132
The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review 131
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 130
Immune-checkpoint inhibitors in renal transplanted patients affected by melanoma: A systematic review 128
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 127
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 127
Biomarkers of response to advanced prostate cancer therapy 126
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 125
Prognostic factors affecting survival after pulmonary resection of metastatic renal cell carcinoma: A multicenter experience 124
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 123
The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration 122
SOMATOSTATIN ANALOGUES VS ACTIVE SURVEILLANCE IN SMALL PANCREATIC NEUROENDOCRINE TUMORS 121
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 120
Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity. 119
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 119
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 117
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 116
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review 116
The Role of Postoperative Radiotherapy in the Management of Dermatofibrosarcoma Protuberans: A Multidisciplinary Systematic Review 116
Upfront Oxaliplatin–Fluoropyrimidine Chemotherapy and Somatostatin Analogues in Advanced Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Tumors 113
Surgical Resection of Pulmonary Metastases from Melanoma in Oligometastatic Patients: Results from a Multicentric Study in the Era of Immunoncology and Targeted Therapy 111
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 111
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study 111
Line-Field Confocal Optical Coherence Tomography Evaluation of Eyelid Skin Lesions 109
The role of postoperative radiotherapy in eccrine porocarcinoma: a multidisciplinary systematic review 109
Efficacy of immune checkpoint inhibitors in different types of melanoma 105
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 103
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 103
Atypical Presentation of Splenic Tissue Mimicking Neuroendocrine Tumor Relapse 102
TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway 102
Unconventional radiotherapy to enhance immunotherapy efficacy in bulky tumors: a case report 100
The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer 98
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 98
A New Easy-to-Perform Flow Cytometry Assay for Determining Bacterial- and Viral-Infection-Induced Polymorphonuclear Neutrophil and Monocyte Membrane Marker Modulation in Febrile Patients 97
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 97
Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer 89
Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in human colon cancer. 88
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. 87
Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment 84
“Skin rashes” and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management 83
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial 79
Direct effects of GnRH agonists in human hormone-sensitive endometrial cells 75
Targeted therapy in advanced gastric carcinoma: The future is beginning 74
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 74
Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study 65
Impact of en bloc extended R0 resections on oncological outcome of locally advanced adrenocortical carcinoma 64
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study 55
No evidence of association between psychological distress and pain relief in patients with bone metastases from castration-resistant prostate cancer treated with 223Radium 54
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis 51
Is 18F-fluorodeoxyglucose the tracer of choice for functional imaging of neuroendocrine tumors grade 3? A case report 46
Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial 23
Endocrine toxicities in immune checkpoint inhibitors and tyrosine kinase inhibitors combined treatment: from clinical trials to real-life practice 12
Immunohistochemical expression of Ki-67, INSM1, and SSTR2A in medullary thyroid carcinoma: correlation with tumour size, vascular invasion, and biochemical outcome 8
Role of B-Mode and Contrast-Enhanced Ultrasound in the Diagnostic Workflow of Gastro-Entero-Pancreatic Neuroendocrine Tumors (GEP-NETs) 6
Primary adrenal insufficiency induced by immune checkpoint inhibitors (ICIs): a case series and systematic literature review 3
Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis 2
Totale 11.351
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.087
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.087
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022636 59 18 15 99 39 14 13 86 33 43 95 122
2022/20231.381 181 178 100 226 57 158 103 121 143 32 59 23
2023/2024762 35 169 47 41 31 111 52 33 14 34 106 89
2024/20251.737 35 54 124 70 144 71 70 59 232 210 321 347
2025/20265.229 598 123 271 628 835 561 936 262 306 269 252 188
2026/2027305 305 0 0 0 0 0 0 0 0 0 0 0
Totale 11.351